Convatec Expects Revenue Hit from US Pricing Decision
Convatec Group PLC has confirmed that a US pricing decision will have a modest impact on revenue in 2026.
The Centers for Medicare & Medicaid Services (CMS) has set a revised payment rate of $127.28 per square centimeter for skin substitutes in wound care, effective January 1, 2026.
- The new rate is around 1.5% ahead of the initially proposed rate.
- The CMS had proposed reducing Medicare spending on skin substitutes by almost 90%.
The decision is expected to represent a 1% to 2% revenue hit for Convatec.
Author's summary: Convatec expects a modest revenue hit from the US pricing decision.
More News
- 5 Breakfasts That Flatten Your Belly After 40
- Ghana Association Of Privacy Professionals (GAPP) Calls For Transparency And Compliance In Management Of Ghana’s Health Data Systems
- Ghana: New L.I. Laid Before Parliament to Revoke Controversial Mining Regulation Law
- The All-Day Detroit-Style Pizza and Natural Wine Bar Has Landed - Hospitality & Catering News
- A Poetic Farewell: Ambassador Maher Kheir reflects on his years in Ghana